Table 2.
Analysis of prognostic factors
| Factor | P | HR | 95% CI | P | HR | 95% CI |
|---|---|---|---|---|---|---|
| Age (years old) | 0.809 | 1.044 | 0.736-1.481 | |||
| Body mass index | 0.519 | 0.86 | 0.545-1.358 | |||
| Ethnicity | 0.079 | 1.422 | 0.96-2.105 | |||
| Marital status | 0.749 | 1.157 | 0.473-2.826 | |||
| Educational level | 0.645 | 0.922 | 0.653-1.302 | |||
| Family history of cancer | 0.514 | 1.228 | 0.663-2.275 | |||
| Intraductal carcinoma of the prostate | 0.833 | 1.06 | 0.619-1.813 | |||
| Neural invasion | <0.001 | 2.309 | 1.54-3.462 | <0.001 | 2.371 | 1.569-3.582 |
| Hypertension | 0.240 | 1.224 | 0.873-1.716 | |||
| Diabetes mellitus | 0.903 | 0.976 | 0.66-1.444 | |||
| T-staging | 0.372 | 1.179 | 0.821-1.692 | |||
| N-staging | 0.245 | 1.236 | 0.865-1.766 | |||
| Gleason score | 0.009 | 1.592 | 1.121-2.261 | 0.002 | 1.787 | 1.241-2.573 |
| Initial PSA | 0.001 | 1.777 | 1.256-2.515 | 0.004 | 1.677 | 1.174-2.396 |
| Testosterone | 0.123 | 0.751 | 0.522-1.081 | |||
| HGB | 0.467 | 1.197 | 0.737-1.944 | |||
| ALP | 0.345 | 1.251 | 0.786-1.993 | |||
| LDH | <0.001 | 2.57 | 1.785-3.7 | <0.001 | 2.729 | 1.855-4.014 |
| ALB | 0.294 | 1.257 | 0.82-1.928 |
Note: PSA: Prostate-specific antigen, HGB: Hemoglobin, ALP: Alkaline phosphatase, LDH: Lactate dehydrogenase, ALB: Albumin.